BackAlkermes plc Overview
Alkermes plc

Alkermes plc Target Price

Analysts' average 12-month price target for Alkermes plc is $59.

Get informed when a big investor buys or sells

+ Follow

Share Price

$47.41

Average Target Price

$58.8324.1% upside

6 analysts in the last 4 months

High: $65 | Low: $50

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-28Piper SandlerDavid Amsellem$6537.1% upsideOpen
2026-07-20Stifel NicolausPaul Matteis$6332.9% upsideOpen
2026-07-02Mizuho SecuritiesVamil Divan$6537.1% upsideOpen
2026-06-18NeedhamAmi Fadia$5413.9% upsideOpen
2026-06-09RBC CapitalLeonid Timashev$5618.1% upsideOpen
2026-05-06Needham$505.5% upsideOpen
2026-02-26H.C. WainwrightDouglas Tsao$439.3% downsideOpen
2026-02-23Wolfe Research$455.1% downsideOpen
2025-10-28JefferiesAkash Tewari$5618.1% upsideOpen
2025-10-27Mizuho Securities$455.1% downsideOpen
2025-10-23Piper SandlerDavid Amsellem$455.1% downsideOpen
2025-10-22RBC Capital$470.9% downsideOpen
2025-09-26RBC CapitalAlkermes to Outperform$447.2% downsideOpen
2025-09-09Needham$439.3% downsideOpen
2025-09-09H.C. WainwrightDouglas Tsao$463% downsideOpen
2025-09-02Wells Fargo$447.2% downsideOpen
2025-06-17UBSAshwani Verma$4211.4% downsideOpen
2024-12-05Piper SandlerDavid Amsellem$3722% downsideOpen
2024-11-13Mizuho SecuritiesVamil Divan$4015.6% downsideOpen
2024-11-04Stifel NicolausPaul Matteis$3624.1% downsideOpen
2024-10-24Stifel NicolausPaul Matteis$2547.3% downsideOpen
2024-10-14H.C. WainwrightDouglas Tsao$3722% downsideOpen
2024-04-10JefferiesAkash Tewari$2547.3% downsideOpen
2024-04-09Mizuho SecuritiesVamil Divan$3526.2% downsideOpen
2024-04-09JefferiesAkash Tewari$2547.3% downsideOpen
2024-03-18Robert W. BairdJoel Beatty$3722% downsideOpen
2022-12-06J.P. Morgan$2938.8% downsideOpen
2022-04-28Leerink Partners$2743% downsideOpen
2022-04-21Leerink Partners$2547.3% downsideOpen
2022-04-20Goldman Sachs$3526.2% downsideOpen

Alkermes plc (ALKS) FAQ

The latest target price for ALKS is $59. Investors often review this figure alongside Alkermes plc's historical trend and sector peers before judging valuation or financial health.

Alkermes plc trades near $47.41 while the consensus target sits at $59 (24.1% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting ALKS's target price ($59), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Alkermes plc's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.